Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
175 hedge funds and large institutions have $805M invested in Natus Medical Inc in 2019 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 45 reducing their positions, and 20 closing their positions.
85% more call options, than puts
Call options by funds: $1.72M | Put options by funds: $929K
50% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 20
44% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 45
4% more funds holding
Funds holding: 168 → 175 (+7)
1% more capital invested
Capital invested by funds: $801M → $805M (+$4.06M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
+$6.28M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$4.68M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.13M |
| 4 |
VCM
Voce Capital Management
San Francisco,
California
|
+$3M |
| 5 |
Renaissance Technologies
New York
|
+$2.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SV
Starboard Value
New York
|
-$14.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.81M |
| 3 |
CIM
Confluence Investment Management
St. Louis,
Missouri
|
-$4.25M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.19M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$2.29M |
NTUS Hedge Fund Activity: Q2 2019 in Review
175 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2019, worth a combined $805M — up 0.51% from $801M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new NTUS positions and 20 closed out — a net gain of 10 holders — while 65 added to existing stakes and 45 trimmed.
The largest buyer was Cramer Rosenthal McGlynn, adding an estimated $6.28M. The largest seller was Starboard Value, cutting an estimated $14.5M.
- 175 institutional investors held Natus Medical Inc (NTUS) as of Q2 2019, up from 168 in Q1 2019.
- Funds reported $805M of Natus Medical Inc stock for Q2 2019, up 0.51% quarter-over-quarter.
- 30 funds opened new Natus Medical Inc positions in Q2 2019 and 20 closed out, a net change of +10 holders.
- The largest Natus Medical Inc buyer in Q2 2019 was Cramer Rosenthal McGlynn, an estimated $6.28M added.
- The largest Natus Medical Inc seller in Q2 2019 was Starboard Value, an estimated $14.5M sold.
Based on aggregated 13F filings for Q2 2019.